Pancoast tumor

Last updated
Pancoast tumor
Other namesPulmonary sulcus tumor, superior sulcus tumor
Pancoast Tumor 1.jpg
Chest X-ray showing a Pancoast tumor (labeled as P, non-small cell lung carcinoma, right lung), from a 47-year-old female smoker.
Specialty Oncology   OOjs UI icon edit-ltr-progressive.svg
Risk factors Smoking

A Pancoast tumor is a tumor of the apex of the lung. It is a type of lung cancer defined primarily by its location situated at the top end of either the right or left lung. It typically spreads to nearby tissues such as the ribs and vertebrae. Most Pancoast tumors are non-small-cell lung cancers.

Contents

The growing tumor can cause compression of many nearby structures, such as the brachiocephalic vein, subclavian artery, phrenic nerve, recurrent laryngeal nerve, vagus nerve, or, characteristically, compression of a sympathetic ganglion (the stellate ganglion), which result in various presenting symptoms, most notably a range of symptoms known as Horner's syndrome due to compression of nearby sympathetic nerves.

Pancoast tumors are named for Henry Pancoast, an American radiologist, who first described them in 1924 and 1932.

Though many advances in their treatment have been made since their initial categorization, Pancoast tumors remain difficult to treat due to low rates of possible surgical intervention, therefore prognosis is still poor. [1]

History

The Pancoast tumor was first described by Hare in 1838 as a "tumor involving certain nerves". [2] It was not until 1924 that the tumor was described in further detail, when Henry Pancoast, a radiologist from Philadelphia, published an article in which he reported and studied many cases of apical chest tumors that all shared the same radiographic findings and associated clinical symptoms, such as pain in the upper extremity following the distribution of the eighth cervical, first and second thoracic nerve trunks, as well as "sympathetic phenomena". [3] Pancoast went on to publish a second article in 1932 in which a name was finally given to the tumor, "superior pulmonary sulcus tumor". [4]

Epidemiology

The Pancoast tumor is one of the more rare forms of lung cancer, only accounting for about 3-5% of lung cancer cases, with lung cancer in general being the second most common type of cancer occurring worldwide. [5] [6]

Like most other lung cancers, Pancoast tumors are more often seen in men and older people, with the average age of diagnosis being between 60–70 years old. [7] [8]

Signs and symptoms

Aside from constitutional symptoms of cancer such as malaise, fever, weight loss and fatigue, most common initial presentation of a Pancoast tumor is that of shoulder pain and upper back pain, present in up to 96% of patients. [7] Typical lung cancer-related pulmonary symptoms, such as shortness of breath, cough and hemoptysis, are often uncommon during the early stages of the disease due to the tumor's peripheral location in the lung. [9]

Typically, other presentations are due to the effects of extension of the tumor into nearby structures, such as ribs, vasculature, and nerves. The results of one of these invasions is the presentation of the Horner's syndrome, which can be seen in 15-50% of patients with severe cases when involvement of the paravertebral sympathetic chain and cervical ganglion occur. [10] A complete Horner's syndrome consists of ipsilateral miosis (constriction of the pupils), anhidrosis (lack of sweating), ptosis (drooping of the eyelid), and pseudoenophthalmos (as a result of the ptosis). In progressive cases, the brachial plexus is also affected, causing pain and weakness in the muscles of the arm and hand with a symptomatology typical of thoracic outlet syndrome. The tumor can also compress the recurrent laryngeal nerve and from this a hoarse voice and "bovine" (non-explosive) cough may occur. [11] [5]

If obstruction of the superior vena cava by the Pancoast tumor occurs, a resulting mass effect called the superior vena cava syndrome occurs, resulting in facial swelling cyanosis and dilatation of the veins of the head and neck. This syndrome can be seen in 5-10% of patient cases. [11]

When the triad of an ipsilateral Horner's syndrome, shoulder/arm pain and weakness of the intrinsic hand muscles occurs, the presentation is called the Pancoast syndrome. This syndrome is due to involvement of brachial plexus roots and that of sympathetic fibers as they exit the cord at T1 and ascend to the superior cervical ganglion. [11] [10]

Causes and risk factors

Due to the location of a Pancoast tumor being in the lung, the main causes are similar to various other causes of lung cancer in general, such as:

Diagnosis

Diagnosis of a Pancoast tumor can be difficult in the early stages to the similarity of its symptoms with other conditions such as arthritis, with shoulder pain being one of the only symptoms that might indicate further imaging for a patient. [14] Though a chest x-ray is a good screening test and might be the first mode of imaging used, they are not easily seen during the early stages of the disease due to their size and location in the chest. [15]

Following the initial imaging, a CT scan or MRI is preferred since both can provide more details and information such as size, lymph node involvement and other areas of invasion, such as vascular involvement. [15] [10]

A biopsy of the lesion is typically required in order to confirm diagnosis and to provide information regarding histology and molecular markers, which in turn allow to assess for best course of treatment. Currently, the most sensitive method is that of a percutaneous transthoracic needle biopsy. [15] [16]

It is important to consider other possible causes with similar physical presentation to the Pancoast tumor. Such conditions to consider as part of a differential diagnosis include:

Tumor staging

Pancoast tumors are staged similarly to most other non-small cell lung cancers using the tumor, node, and metastasis (TNM system) as well as numbers (1-4) to indicate severity. [12] At time of diagnosis, due to difficulty of early detection through imaging, most Pancoast tumors are usually staged at level T3 or T4 due to their invasion of the chest wall and local nerve structures. [15]

Prognosis

Advances in treatment and research have greatly improved survival rates over time, yet due to the later detection of most Pancoast tumors, the prognosis of the disease is still not always favorable and varies depending various factors such as time of detection, extent of invasion of the tumor, lymph node involvement and whether or not the tumor is resectable. [5]

Currently, the five year prognosis on average is about 30% and up to 50% in patients with early-stage and surgically resectable Pancoast tumors. [12] Unfortunately, less than 50% of tumors found in patients are actually surgically resectable, leading to poorer outcomes. [15]

Treatment and management

The treatment of a Pancoast lung cancer may differ from that of other types of non-small-cell lung cancer. The current standard of treatment is a combination of chemotherapy and radiotherapy, followed by surgical resection. [20] Though complete tumor resection is recommended, its position and close proximity to vital structures (such as nerves and the spine) may make surgical intervention difficult, with many absolute contraindications present such as tumor invasion of the esophagus/trachea, more than 50% vertebral involvement among a few. [5]

As a result, and depending on the stage of the cancer, treatment may involve radiation therapy and chemotherapy given prior to surgery (neoadjuvant treatment). Surgery may consist of the removal of the upper lobe of a lung together with its associated structures (subclavian artery, vein, branches of the brachial plexus, ribs and vertebral bodies), as well as mediastinal lymphadenectomy. Surgical access may be via thoracotomy from the back or the front of the chest and modifications. Nonsurgical treatment may consist of radiation therapy alone or clinical trials of new combinations of treatment.

Related Research Articles

<span class="mw-page-title-main">Lung cancer</span> Malignant tumor characterized by uncontrolled cell growth in lung tissue

Lung cancer, also known as lung carcinoma, is a malignant tumor that begins in the lung. Lung cancer is caused by genetic damage to the DNA of cells in the airways, often caused by cigarette smoking or inhaling damaging chemicals. Damaged airway cells gain the ability to multiply unchecked, causing the growth of a tumor. Without treatment, tumors spread throughout the lung, damaging lung function. Eventually lung tumors metastasize, spreading to other parts of the body.

<span class="mw-page-title-main">Ramsay Hunt syndrome type 2</span> Presentation of shingles in the geniculate ganglion

Ramsay Hunt syndrome type 2, commonly referred to simply as Ramsay Hunt syndrome (RHS) and also known as herpes zoster oticus, is inflammation of the geniculate ganglion of the facial nerve as a late consequence of varicella zoster virus (VZV). In regard to the frequency, less than 1% of varicella zoster infections involve the facial nerve and result in RHS. It is traditionally defined as a triad of ipsilateral facial paralysis, otalgia, and vesicles close to the ear and auditory canal. Due to its proximity to the vestibulocochlear nerve, the virus can spread and cause hearing loss, tinnitus, and vertigo. It is common for diagnoses to be overlooked or delayed, which can raise the likelihood of long-term consequences. It is more complicated than Bell's palsy. Therapy aims to shorten its overall length, while also providing pain relief and averting any consequences.

<span class="mw-page-title-main">Sciatica</span> Lower back pain that extends down leg

Sciatica is pain going down the leg from the lower back. This pain may go down the back, outside, or front of the leg. Onset is often sudden following activities like heavy lifting, though gradual onset may also occur. The pain is often described as shooting. Typically, symptoms are only on one side of the body. Certain causes, however, may result in pain on both sides. Lower back pain is sometimes present. Weakness or numbness may occur in various parts of the affected leg and foot.

<span class="mw-page-title-main">Abdominal pain</span> Stomach aches

Abdominal pain, also known as a stomach ache, is a symptom associated with both non-serious and serious medical issues. Since the abdomen contains most of the body's vital organs, it can be an indicator of a wide variety of diseases. Given that, approaching the examination of a person and planning of a differential diagnosis is extremely important.

Spinal tumors are neoplasms located in either the vertebral column or the spinal cord. There are three main types of spinal tumors classified based on their location: extradural and intradural. Extradural tumors are located outside the dura mater lining and are most commonly metastatic. Intradural tumors are located inside the dura mater lining and are further subdivided into intramedullary and extramedullary tumors. Intradural-intramedullary tumors are located within the dura and spinal cord parenchyma, while intradural-extramedullary tumors are located within the dura but outside the spinal cord parenchyma. The most common presenting symptom of spinal tumors is nocturnal back pain. Other common symptoms include muscle weakness, sensory loss, and difficulty walking. Loss of bowel and bladder control may occur during the later stages of the disease.

<span class="mw-page-title-main">Atelectasis</span> Partial collapse of a lung causing reduced gas exchange

Atelectasis is the partial collapse or closure of a lung resulting in reduced or absent gas exchange. It is usually unilateral, affecting part or all of one lung. It is a condition where the alveoli are deflated down to little or no volume, as distinct from pulmonary consolidation, in which they are filled with liquid. It is often referred to informally as a collapsed lung, although more accurately it usually involves only a partial collapse, and that ambiguous term is also informally used for a fully collapsed lung caused by a pneumothorax.

<span class="mw-page-title-main">Horner's syndrome</span> Facial disorder due to damage of the sympathetic nerves

Horner's syndrome, also known as oculosympathetic paresis, is a combination of symptoms that arises when a group of nerves known as the sympathetic trunk is damaged. The signs and symptoms occur on the same side (ipsilateral) as it is a lesion of the sympathetic trunk. It is characterized by miosis, partial ptosis, apparent anhidrosis, with apparent enophthalmos.

<span class="mw-page-title-main">Recurrent laryngeal nerve</span> Nerve in the human body

The recurrent laryngeal nerve (RLN) is a branch of the vagus nerve that supplies all the intrinsic muscles of the larynx, with the exception of the cricothyroid muscles. There are two recurrent laryngeal nerves, right and left. The right and left nerves are not symmetrical, with the left nerve looping under the aortic arch, and the right nerve looping under the right subclavian artery, then traveling upwards. They both travel alongside the trachea. Additionally, the nerves are among the few nerves that follow a recurrent course, moving in the opposite direction to the nerve they branch from, a fact from which they gain their name.

<span class="mw-page-title-main">Stellate ganglion</span> Component of the human nervous system

The stellate ganglion is a sympathetic ganglion formed by the fusion of the inferior cervical ganglion and the first thoracic ganglion, which is present in 80% of individuals. Sometimes, the second and the third thoracic ganglia are included in this fusion.

<span class="mw-page-title-main">Pterygopalatine ganglion</span> Parasympathetic ganglion in the pterygopalatine fossa

The pterygopalatine ganglion is a parasympathetic ganglion in the pterygopalatine fossa. It is one of four parasympathetic ganglia of the head and neck,.

<span class="mw-page-title-main">Hamartoma</span> Tumour-like overgrowth due to a systemic genetic condition

A hamartoma is a mostly benign, local malformation of cells that resembles a neoplasm of local tissue but is usually due to an overgrowth of multiple aberrant cells, with a basis in a systemic genetic condition, rather than a growth descended from a single mutated cell (monoclonality), as would typically define a benign neoplasm/tumor. Despite this, many hamartomas are found to have clonal chromosomal aberrations that are acquired through somatic mutations, and on this basis the term hamartoma is sometimes considered synonymous with neoplasm. Hamartomas are by definition benign, slow-growing or self-limiting, though the underlying condition may still predispose the individual towards malignancies.

<span class="mw-page-title-main">Nerve block</span> Deliberate inhibition of nerve impulses

Nerve block or regional nerve blockade is any deliberate interruption of signals traveling along a nerve, often for the purpose of pain relief. Local anesthetic nerve block is a short-term block, usually lasting hours or days, involving the injection of an anesthetic, a corticosteroid, and other agents onto or near a nerve. Neurolytic block, the deliberate temporary degeneration of nerve fibers through the application of chemicals, heat, or freezing, produces a block that may persist for weeks, months, or indefinitely. Neurectomy, the cutting through or removal of a nerve or a section of a nerve, usually produces a permanent block. Because neurectomy of a sensory nerve is often followed, months later, by the emergence of new, more intense pain, sensory nerve neurectomy is rarely performed.

Meralgia paresthetica or meralgia paraesthetica is pain or abnormal sensations in the outer thigh not caused by injury to the thigh, but by injury to a nerve which provides sensation to the lateral thigh.

<span class="mw-page-title-main">Respiratory disease</span> Disease of the respiratory system

Respiratory diseases, or lung diseases, are pathological conditions affecting the organs and tissues that make gas exchange difficult in air-breathing animals. They include conditions of the respiratory tract including the trachea, bronchi, bronchioles, alveoli, pleurae, pleural cavity, the nerves and muscles of respiration. Respiratory diseases range from mild and self-limiting, such as the common cold, influenza, and pharyngitis to life-threatening diseases such as bacterial pneumonia, pulmonary embolism, tuberculosis, acute asthma, lung cancer, and severe acute respiratory syndromes, such as COVID-19. Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause of the disease.

<span class="mw-page-title-main">Lumbar ganglia</span>

The lumbar ganglia are paravertebral ganglia located in the inferior portion of the sympathetic trunk. The lumbar portion of the sympathetic trunk typically has 4 lumbar ganglia. The lumbar splanchnic nerves arise from the ganglia here, and contribute sympathetic efferent fibers to the nearby plexuses. The first two lumbar ganglia have both white and gray rami communicates.

<span class="mw-page-title-main">Nerve compression syndrome</span> Human medical condition

Nerve compression syndrome, or compression neuropathy, or nerve entrapment syndrome, is a medical condition caused by chronic, direct pressure on a peripheral nerve. It is known colloquially as a trapped nerve, though this may also refer to nerve root compression. Its symptoms include pain, tingling, numbness and muscle weakness. The symptoms affect just one particular part of the body, depending on which nerve is affected. The diagnosis is largely clinical and can be confirmed with diagnostic nerve blocks. Occasionally imaging and electrophysiology studies aid in the diagnosis. Timely diagnosis is important as untreated chronic nerve compression may cause permanent damage. A surgical nerve decompression can relieve pressure on the nerve but cannot always reverse the physiological changes that occurred before treatment. Nerve injury by a single episode of physical trauma is in one sense an acute compression neuropathy but is not usually included under this heading, as chronic compression takes a unique pathophysiological course.

<span class="mw-page-title-main">Adenocarcinoma of the lung</span> Medical condition

Adenocarcinoma of the lung is the most common type of lung cancer, and like other forms of lung cancer, it is characterized by distinct cellular and molecular features. It is classified as one of several non-small cell lung cancers (NSCLC), to distinguish it from small cell lung cancer which has a different behavior and prognosis. Lung adenocarcinoma is further classified into several subtypes and variants. The signs and symptoms of this specific type of lung cancer are similar to other forms of lung cancer, and patients most commonly complain of persistent cough and shortness of breath.

Interventional pain management or interventional pain medicine is a medical subspecialty defined by the National Uniforms Claims Committee (NUCC) as, " invasive interventions such as the discipline of medicine devoted to the diagnosis and treatment of pain related disorders principally with the application of interventional techniques in managing sub acute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment". Medicare Payment Advisory Commission (MedPAC) defined interventional techniques as, "minimally invasive procedures including, percutaneous precision needle placement, with placement of drugs in targeted areas or ablation of targeted nerves; and some surgical techniques such as laser or endoscopic diskectomy, intrathecal infusion pumps and spinal cord stimulators, for the diagnosis and management of chronic, persistent or intractable pain". Minimally invasive interventions such as facet joint injections, nerve blocks, neuroaugmentation, vertebroplasty, kyphoplasty, nucleoplasty, endoscopic discectomy, and implantable drug delivery systems are utilized in managing subacute or chronic pain.

Cancer pain can be caused by pressure on, or chemical stimulation of, specialised pain-signalling nerve endings called nociceptors, or by damage or illness affecting nerve fibers themselves.

<span class="mw-page-title-main">Sensory neuronopathy</span> Sensory neuropathy caused by damage of nerve cells in the dorsal root ganglion

Sensory neuronopathy is a type of peripheral neuropathy that results primarily in sensory symptoms due to destruction of nerve cell bodies in the dorsal root ganglion. The causes of nerve damage are grouped into categories including those due to paraneoplastic causes, immune mediated, infectious, inherited or degenerative causes and those due to toxin exposure. In idiopathic sensory neuronopathy no cause is identified. Idiopathic causes account for about 50% of cases. Sensory neuronopathy differs from the more common length dependent axonal polyneuropathies in that the symptoms do not progress in a distal to proximal pattern, rather symptoms develop in a multifocal, asymmetric, and non-length dependent manner. Ataxia is a prominent symptom early in the disease course. The trigeminal nerve ganglion is also commonly affected leading to facial numbness. Motor nerves are usually not affected however some cases do have mild motor involvement in the form of weakness. Symptoms tend to develop sub-acutely, over weeks, in acquired sensory neuronopathy and more slowly in inherited or primary degenerative cases. In cases of paraneoplastic or infectious sensory neuropathy, treatment is directed at the underlying cancer or infectious cause respectively. Immunomodulatory and anti-inflammatory therapies are also commonly used however their effectiveness is limited.

References

  1. ↑ synd/2953 at Who Named It?
  2. ↑ Hare E (1838). "Tumor involving certain nerves". London Med Gazette. 1: 16–18.
  3. ↑ Pancoast HK (November 1924). "Importance of Careful Roentgen-Ray Investigations of Apical Chest Tumors". JAMA: The Journal of the American Medical Association. 83 (18): 1407. doi:10.1001/jama.1924.02660180025007. ISSN   0098-7484.
  4. ↑ Pancoast HK (1932-10-22). "Superior Pulmonary Sulcus Tumor: Tumor Characterized by Pain, Horner's Syndrome, Destruction of Bone and Atrophy of Hand Muscles – Chairman's Address". Journal of the American Medical Association. 99 (17): 1391. doi:10.1001/jama.1932.02740690001001. ISSN   0002-9955.
  5. 1 2 3 4 Marulli, Giuseppe; Battistella, Lucia; Mammana, Marco; Calabrese, Francesca; Rea, Federico (June 2016). "Superior sulcus tumors (Pancoast tumors)". Annals of Translational Medicine. 4 (12): 239. doi: 10.21037/atm.2016.06.16 . PMC   4930518 . PMID   27429965.
  6. ↑ "Worldwide cancer data". World Cancer Research Fund International. Retrieved 2023-11-08.
  7. 1 2 Gundepalli SG, Tadi P (2023). "Lung Pancoast Tumor". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   32310569 . Retrieved 2023-11-13.
  8. ↑ "Lung Cancer Statistics | How Common is Lung Cancer?". American Cancer Society. Retrieved 2023-11-13.
  9. 1 2 Adams M (October 2022). "3 facts about Pancoast tumors". MD Anderson Cancer Center. Retrieved 2023-11-13.
  10. 1 2 3 Villgran VD, Chakraborty RK, Cherian SV (2023). "Pancoast Syndrome". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   29489146 . Retrieved 2023-11-13.
  11. 1 2 3 Arcasoy SM, Schild SE, Leal T (January 2023). Lilenbaum RC, Vallières E, Vora SR, Finlay G (eds.). "Superior pulmonary sulcus (Pancoast) tumors". UpToDate. Retrieved 2023-11-08.
  12. 1 2 3 "Pancoast Tumors: Symptoms, Causes & Treatment". Cleveland Clinic. Retrieved 2023-11-07.
  13. ↑ "Risk Factors for Pancoast Tumors". Moffitt Cancer Center. Retrieved 2023-11-08.
  14. ↑ "Pancoast Tumor Diagnosis". Moffitt Cancer Center. Retrieved 2023-11-07.
  15. 1 2 3 4 5 Panagopoulos N, Leivaditis V, Koletsis E, Prokakis C, Alexopoulos P, Baltayiannis N, et al. (March 2014). "Pancoast tumors: characteristics and preoperative assessment". Journal of Thoracic Disease. 6 (Suppl 1): S108–S115. doi:10.3978/j.issn.2072-1439.2013.12.29. PMC   3966151 . PMID   24672686.
  16. ↑ Walls WJ, Thornbury JR, Naylor B (April 1974). "Pulmonary needle aspiration biopsy in the diagnosis of Pancoast tumors". Radiology. 111 (1): 99–102. doi:10.1148/111.1.99. PMID   4816129.
  17. ↑ Gundepalli, Sai Giridhar; Tadi, Prasanna (2023), "Lung Pancoast Tumor", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   32310569 , retrieved 2023-11-13
  18. ↑ "UpToDate". www.uptodate.com. Retrieved 2023-11-08.
  19. ↑ Villgran, Vipin D.; Chakraborty, Rebanta K.; Cherian, Sujith V. (2023), "Pancoast Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29489146 , retrieved 2023-11-13
  20. ↑ Gundepalli, Sai Giridhar; Tadi, Prasanna (2023), "Lung Pancoast Tumor", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   32310569 , retrieved 2023-11-14

PD-icon.svg This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.